DcR2 Antibodies
Choose one of 75 DcR2 antibodies from our product listing based on 6 publications and 34 validation images.
Explore reliable DcR2 antibodies from a broad selection of renowned manufacturers. Our portfolio enables accurate DcR2 detection across multiple species, including Human, Mouse, Rat, Monkey, and supports diverse research applications such as WB, ELISA, FACS, IHC, ICC.
Quickly find the right antibody using our search, filter, and comparison tools. Each product page provides detailed validation data, literature references, and customer feedback. Unlike comparison-only resources, you can conveniently purchase antibodies directly through our site. Choose from polyclonal, monoclonal, or recombinant DcR2 antibodies derived from various hosts such as Rabbit, Mouse. Browse our products below and order directly to support your research with confidence.
Alternative names for DcR2 are TNFRSF10D, LOC716901.
Recommended next Filters:
Would you like to try our new AI Search?
75 results
Latest Publications for our DcR2 Antibodies
: "Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells." in: PLoS ONE, Vol. 14, Issue 4, pp. e0214847, (2019) (PubMed).: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer." in: Cancers, Vol. 11, Issue 9, (2019) (PubMed).
: "Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells." in: Cell death & disease, Vol. 8, Issue 8, pp. e3025, (2018) (PubMed).
: "Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps." in: PLoS ONE, Vol. 13, Issue 6, pp. e0198203, (2018) (PubMed).
: "TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis." in: Scientific reports, Vol. 7, Issue 1, pp. 5514, (2017) (PubMed).
: "Targeting Apoptotic Activity Against Prostate Cancer Stem Cells." in: International journal of molecular sciences, Vol. 18, Issue 8, (2017) (PubMed).
: "Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells." in: Stem cell research & therapy, Vol. 8, Issue 1, pp. 201, (2017) (PubMed).
: "The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2." in: Molecular cell, Vol. 65, Issue 4, pp. 730-742.e5, (2017) (PubMed).
: "Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 23, pp. 5338-48, (2015) (PubMed).
Aliases for DcR2 Antibodies
TNF receptor superfamily member 10d (TNFRSF10D) Antibodiestumor necrosis factor receptor superfamily member 10D (LOC716901) Antibodies
CD264 Antibodies
DCR2 Antibodies
TNFRSF10D Antibodies
TRAIL-R4 Antibodies
TRAILR4 Antibodies
TRUNDD Antibodies
Did you look for something else?
- DcR1 Antibodies
- DCPS Antibodies
- DCP2 Antibodies
- DCP1B Antibodies
- DCP1A Antibodies
- DCMP Deaminase Antibodies
- DCLRE1C Antibodies
- DCLRE1B Antibodies
- DCLK3 Antibodies
- DCLK2 Antibodies
- DCLK1 Antibodies
- DCL1 Antibodies
- DCK Antibodies
- DCI Antibodies
- DCHS1 Antibodies
- DCDC5 Antibodies
- DCDC2B Antibodies
- DCDC2 Antibodies
- DCC Antibodies
- DCBLD2 Antibodies
- DCST1 Antibodies
- DCT Antibodies
- DCTN3 Antibodies
- DCTN5 Antibodies
- DCTN6 Antibodies
- DCTPP1 Antibodies
- DCUN1D1 Antibodies
- DCUN1D2 Antibodies
- DCUN1D3 Antibodies
- DCUN1D4 Antibodies
- DCXR Antibodies
- DcyD Antibodies
- DDA1 Antibodies
- DDAH1 Antibodies
- DDAH2 Antibodies
- DDB1 Antibodies
- DDB2 Antibodies
- DDC Antibodies
- DDHD1 Antibodies
- DDHD2 Antibodies
